BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10828009)

  • 1. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation.
    Price TH; Bowden RA; Boeckh M; Bux J; Nelson K; Liles WC; Dale DC
    Blood; 2000 Jun; 95(11):3302-9. PubMed ID: 10828009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation.
    Adkins DR; Goodnough LT; Shenoy S; Brown R; Moellering J; Khoury H; Vij R; DiPersio J
    Blood; 2000 Jun; 95(11):3605-12. PubMed ID: 10828051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis.
    Grigull L; Pulver N; Goudeva L; Sykora KW; Linderkamp C; Beilken A; Seidemann K; Schmid H; Welte K; Heuft HG
    Support Care Cancer; 2006 Sep; 14(9):910-6. PubMed ID: 16622651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte transfusion combined with granulocyte colony stimulating factor in severe infection patients with severe aplastic anemia: a single center experience from China.
    Wang H; Wu Y; Fu R; Qu W; Ruan E; Wang G; Liu H; Song J; Xing L; Guan J; Li L; Liu C; Shao Z
    PLoS One; 2014; 9(2):e88148. PubMed ID: 24505406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study.
    Dignani MC; Anaissie EJ; Hester JP; O'Brien S; Vartivarian SE; Rex JH; Kantarjian H; Jendiroba DB; Lichtiger B; Andersson BS; Freireich EJ
    Leukemia; 1997 Oct; 11(10):1621-30. PubMed ID: 9324280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined administration of G-CSF and dexamethasone for the mobilization of granulocytes in normal donors: optimization of dosing.
    Liles WC; Rodger E; Dale DC
    Transfusion; 2000 Jun; 40(6):642-4. PubMed ID: 10864982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Return of granulocyte transfusions.
    Dale DC; Liles WC
    Curr Opin Pediatr; 2000 Feb; 12(1):18-22. PubMed ID: 10676769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-donor granulocyte transfusions for improving the outcome of high-risk pediatric patients with known bacterial and fungal infections undergoing stem cell transplantation: a 10-year single-center experience.
    Nikolajeva O; Mijovic A; Hess D; Tatam E; Amrolia P; Chiesa R; Rao K; Silva J; Veys P
    Bone Marrow Transplant; 2015 Jun; 50(6):846-9. PubMed ID: 25822222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients.
    Peters C; Minkov M; Matthes-Martin S; Pötschger U; Witt V; Mann G; Höcker P; Worel N; Stary J; Klingebiel T; Gadner H
    Br J Haematol; 1999 Sep; 106(3):689-96. PubMed ID: 10468857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone.
    Dale DC; Liles WC; Llewellyn C; Rodger E; Price TH
    Transfusion; 1998 Aug; 38(8):713-21. PubMed ID: 9709778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dose-response analysis of lenograstim plus dexamethasone for neutrophil mobilization and collection.
    Heuft HG; Goudeva L; Pulver N; Grigull L; Schwella N; Blasczyk R
    Transfusion; 2005 Apr; 45(4):604-12. PubMed ID: 15819683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases.
    Hübel K; Dale DC; Engert A; Liles WC
    J Infect Dis; 2001 Jan; 183(2):321-328. PubMed ID: 11112098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value and practicality of granulocyte transfusion: a single oncology centre experience.
    Al-Tanbal H; Al Humaidan H; Al-Nounou R; Roberts G; Tesfamichael K; Owaidah T
    Transfus Med; 2010 Jun; 20(3):160-8. PubMed ID: 20070613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.
    Cesaro S; Chinello P; De Silvestro G; Marson P; Picco G; Varotto S; Pittalis S; Zanesco L
    Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia.
    Lowenthal RM; Grossman L; Goldman JM; Storring RA; Buskard NA; Park DS; Murphy BC; Spiers AS; Galton DA
    Lancet; 1975 Feb; 1(7903):353-8. PubMed ID: 46510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of G-CSF-induced granulocyte mobilization in healthy subjects: effects of route of administration and addition of dexamethasone.
    Stroncek DF; Matthews CL; Follmann D; Leitman SF
    Transfusion; 2002 May; 42(5):597-602. PubMed ID: 12084168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers.
    Liles WC; Huang JE; Llewellyn C; SenGupta D; Price TH; Dale DC
    Transfusion; 1997 Feb; 37(2):182-7. PubMed ID: 9051093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte transfusion therapy.
    Marfin AA; Price TH
    J Intensive Care Med; 2015 Feb; 30(2):79-88. PubMed ID: 23920161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors.
    Hübel K; Carter RA; Liles WC; Dale DC; Price TH; Bowden RA; Rowley SD; Chauncey TR; Bensinger WI; Boeckh M
    Transfusion; 2002 Nov; 42(11):1414-21. PubMed ID: 12421213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.
    Negrin RS; Haeuber DH; Nagler A; Olds LC; Donlon T; Souza LM; Greenberg PL
    Ann Intern Med; 1989 Jun; 110(12):976-84. PubMed ID: 2471429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.